Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-44581
Grünblatt, E; Bartl, J; Riederer, P (2011). The link between iron, metabolic syndrome, and Alzheimer's disease. Journal of Neural Transmission, 118(3):371-379.
- Registered users only
Both Alzheimer's disease (AD), the most common form of dementia, and type-2 diabetes mellitus (T2DM), a disease associated with metabolic syndrome (MetS), affect a great number of the world population and both have increased prevalence with age. Recently, many studies demonstrated that pre-diabetes, MetS, and T2DM are risk factors in the development of AD and have many common mechanisms. The main focus of studies is the insulin resistance outcome found both in MetS as well as in brains of AD subjects. However, oxidative stress (OS)-related mechanisms, which are well known to be involved in AD, including mitochondrial dysfunction, elevated iron concentration, reactive oxygen species (ROS), and stress-related enzyme or proteins (e.g. heme oxygenase-1, transferrin, etc.), have not been elucidated in MetS or T2DM brains although OS and iron are involved in the degeneration of the pancreatic islet beta cells. Therefore, this review sets to cover the current literature regarding OS and iron in MetS and T2DM and the similarities to mechanisms in AD both in human subjects as well as in animal models.
|Item Type:||Journal Article, refereed, further contribution|
|Communities & Collections:||04 Faculty of Medicine > Center for Child and Adolescent Psychiatry|
|DDC:||610 Medicine & health|
|Deposited On:||04 Feb 2011 15:28|
|Last Modified:||27 Nov 2013 22:07|
|Citations:||Web of Science®. Times Cited: 7|
Scopus®. Citation Count: 10
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page